Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IDT AustraliaFRA:BM9 Forward Dividend Yield % is 0.00% as of Aug. 09, 2026. The stock has 6 warning signs investors should review. Among 509 Drug Manufacturers companies, IDT Australia ranks worse than 196463.46% on this metric.
As of today (2026-08-09), the Forward Annual Dividend Yield of IDT Australia is 0.00%.
As of today (2026-08-09), the Trailing Annual Dividend Yield of IDT Australia is 0.00%.
FRA:BM9's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.99 * Ranked among companies with meaningful Forward Dividend Yield % only.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of IDT Australia was 84.20% per year. The lowest was -26.30% per year. And the median was 14.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
IDT Australia (FRA:BM9) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
IDT Australia Forward Dividend Yield % Related Terms
FRA:BM9 vs ZTS: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, IDT Australia's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDT Australia Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IDT Australia's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where IDT Australia's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
IDT Australia (FRA:BM9) has a Forward Dividend Yield % of 0.00% as of Aug. 09, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on IDT Australia and its competitors. According to the industry distribution chart, IDT Australia ranks #999999 out of 509 companies in the Drug Manufacturers industry.
Is IDT Australia's Forward Dividend Yield % too high?
IDT Australia's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, IDT Australia ranks #999999 out of 509 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does IDT Australia's Forward Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IDT Australia ranks #999999 out of 509 companies for Forward Dividend Yield %. This places IDT Australia in the lower half of its industry. The industry median Forward Dividend Yield % is 1.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 1.99, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on IDT Australia and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDT Australia's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDT Australia stock overvalued right now?
IDT Australia (FRA:BM9) has a current Forward Dividend Yield % of 0.00%. The stock's GF Value™ is €0.04, compared to a current price of €0.01 — trading 75% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For IDT Australia (FRA:BM9), the current Forward Dividend Yield % is 0.00% as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services. The company operates in Australia, Asia, Europe, and the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:BM9 has been successfully added to your 
